All Stories

  1. Central and Peripheral Alterations of Retinal and Choroidal Vasculature in Multiple Sclerosis: Insights from Multimodal Imaging
  2. Quantification of retinal microvascular imaging features from fundus photos in ocular and systemic disease: a framework for standardization
  3. REACT-PXE: a consensus on diagnosis and future research concerning pseudoxanthoma elasticum (PXE)
  4. Levodopa in retinal disease: Dopamine pathways, neuroprotective mechanisms, and clinical evidence
  5. Investigating the Association between Cognitive Function with Retinal Thickness, Choroidal Thickness and Lens Opacities in People with and without Down Syndrome
  6. Retinal biomarkers for Alzheimer's disease in the prodromal and preclinical population ‐ The Deep and Frequent Phenotyping study
  7. Zinc in eye health, retinal biology and disease
  8. Development of Bioceramic Bone-Inspired Scaffolds Through Single-Step Melt-Extrusion 3D Printing for Segmental Defect Treatment
  9. 2024 Annual Meeting of the International Network on Ectopic Calcification (INTEC)—Abstract Proceedings
  10. Investigating the eye in Down syndrome as a window to Alzheimer’s disease: the REVEAL protocol – a clinical cross-sectional study
  11. International reporting guidelines for tear fluid research: A Delphi consensus
  12. A comprehensive scoping review of methodological approaches and clinical applications of tear fluid biomarkers
  13. Choroidal and retinal vascular changes in adults with Down syndrome: Insights into the Alzheimer's disease continuum
  14. Resistance and resilience to Alzheimer's disease in Down syndrome
  15. Ultra‐widefield retinal imaging in Down syndrome: A high‐risk population for Alzheimer's disease
  16. Dementia risk reduction in the African context: Multi‐national implementation of multimodal strategies to promote healthy brain aging in Africa (the Africa‐FINGERS project)
  17. Development of dual drug loaded-hydrogel scaffold combining microfluidics and coaxial 3D-printing for intravitreal implantation
  18. Application of Artificial Intelligence in Ophthalmology: An Updated Comprehensive Review
  19. Metabolomic changes in tear fluid following zinc biofortification in the BiZiFED nutritional study: a feasibility study
  20. Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation
  21. Bruch's Membrane Calcification in Pseudoxanthoma Elasticum
  22. Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions
  23. Reduced Cone Density Is Associated with Multiple Sclerosis
  24. Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
  25. Two-Photon Excited Fluorescence Lifetime Imaging of Tetracycline-Labeled Retinal Calcification
  26. Editorial: Zinc in health and disease management
  27. Altered zinc homeostasis in a primary cell culture model of the retinal pigment epithelium
  28. Fluorescence Lifetime Imaging of Human Sub-RPE Calcification In Vitro Following Chlortetracycline Infusion
  29. Optimised plasma sample preparation and LC‐MS analysis to support large‐scale proteomic analysis of clinical trial specimens: Application to the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial
  30. Zinc Supplementation Induced Transcriptional Changes in Primary Human Retinal Pigment Epithelium: A Single-Cell RNA Sequencing Study to Understand Age-Related Macular Degeneration
  31. Retinal Vascular Changes in Alzheimer's Dementia and Mild Cognitive Impairment: A Pilot Study Using Ultra-Widefield Imaging
  32. Ocular Biomarkers for Alzheimer Disease Dementia
  33. Zinc supplementation induced transcriptional changes in primary human retinal pigment epithelium: a single cell RNA sequencing study to understand age-related macular degeneration
  34. Nuclear and cellular, micro and nano calcification in Alzheimer's disease patients and correlation to phosphorylated Tau
  35. Re: Keenan et al.: Cluster Analysis and Genotype-Phenotype Assessment of Geographic Atrophy in Age-Related Macular Degeneration: AREDS2 Report 25 (Ophthalmology. 2021;5(11):1061-1073)
  36. A 2,7-dichlorofluorescein derivative to monitor microcalcifications
  37. A Potential New Role for Zinc in Age-Related Macular Degeneration through Regulation of Endothelial Fenestration
  38. Development of a Genotype Assay for Age-Related Macular Degeneration
  39. Characterization of Calcium Phosphate Spherical Particles in the Subretinal Pigment Epithelium–Basal Lamina Space in Aged Human Eyes
  40. Comment and response to the article “The clinical relevance of visualizing the peripheral retina”by Nicola Quinn, Lajos Csincsik, Erin Flynn, Christine A. Curcio, Szilard Kiss, SriniVas R. Sadda, Ruth Hogg, Tunde Peto & Imre Lengyel.
  41. Predicting Progression to Advanced Age-Related Macular Degeneration from Clinical, Genetic, and Lifestyle Factors Using Machine Learning
  42. Increased choroidal thickness in adults with Down syndrome
  43. Multiplex bioimaging of proteins-related to neurodegenerative diseases in eye sections by laser ablation - Inductively coupled plasma – Mass spectrometry using metal nanoclusters as labels
  44. Retinal phenotyping of variants of Alzheimer's disease using ultra‐widefield retinal images
  45. Genotype- and Phenotype-Based Subgroups in Geographic Atrophy Secondary to Age-Related Macular Degeneration
  46. Integrating Metabolomics, Genomics, and Disease Pathways in Age-Related Macular Degeneration
  47. A Multi-Omics Approach Identifies Key Regulatory Pathways Induced by Long-Term Zinc Supplementation in Human Primary Retinal Pigment Epithelium
  48. Fluorescent Arylphosphonic Acids: Synergic Interactions between Bone and the Fluorescent Core
  49. Nuclear and cellular, micro and nano calcification in Alzheimer’s disease patients and correlation to phosphorylated Tau
  50. Imaging hydroxyapatite in sub-retinal pigment epithelial deposits by fluorescence lifetime imaging microscopy with tetracycline staining
  51. Calcium, Diet, Imaging, and Age-Related Macular Degeneration
  52. Determination of Zn, Cu and Fe in human patients' serum using micro-sampling ICP-MS and sample dilution
  53. Correction to: Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia
  54. Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer’s disease
  55. P1‐273: ASSESSING HETEROGENEITY OF ALZHEIMER'S DISEASE THROUGH THE EYE
  56. Zinc Nutrition and Inflammation in the Aging Retina
  57. Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway
  58. THU0663 DO ANTIBODIES DIRECTED AGAINST HUMAN CILIARY BODY TISSUE PREDICT THE DEVELOPMENT OF UVEITIS IN JIA- A PRELIMINARY STUDY
  59. The Placental Growth Factor Pathway and Its Potential Role in Macular Degenerative Disease
  60. On the origin of proteins in human drusen: The meet, greet and stick hypothesis
  61. Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer’s disease
  62. Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration
  63. Mediterranean Diet and Incidence of Advanced Age-Related Macular Degeneration
  64. Fluorescence Lifetime Imaging of Tetracycline-Stained Retinal Hydroxyapatite: An Early Biomarker for Age-Related Macular Degeneration?
  65. Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia
  66. Metabolomics and Age-Related Macular Degeneration
  67. Calcified nodules in retinal drusen are associated with disease progression in age-related macular degeneration
  68. A new perspective on lipid research in age-related macular degeneration
  69. The clinical relevance of visualising the peripheral retina
  70. Obesity, diabetes and zinc: A workshop promoting knowledge and collaboration between the UK and Israel, november 28–30, 2016 – Israel
  71. Precision medicine for age-related macular degeneration: current developments and prospects
  72. Genetic differences can cause changes in the level of several proteins in blood samples
  73. The effects of zinc supplementation on primary human retinal pigment epithelium
  74. Towards early detection of age-related macular degeneration with tetracyclines and FLIM
  75. Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration
  76. Peripheral Retinal Imaging Biomarkers for Alzheimer’s Disease: A Pilot Study
  77. Localization of the zinc binding tubulin polymerization promoting protein in the mice and human eye
  78. Prevalence of Age-Related Macular Degeneration in Europe
  79. Changes in zinc status and zinc transporters expression in whole blood of patients with Systemic Inflammatory Response Syndrome (SIRS)
  80. Subretinal Pigment Epithelial Deposition of Drusen Components Including Hydroxyapatite in a Primary Cell Culture Model
  81. Main biomarkers associated with age-related plasma zinc decrease and copper/zinc ratio in healthy elderly from ZincAge study
  82. RETINAL IMAGING IN POSTERIOR CORTICAL ATROPHY AND TYPICAL ALZHEIMER’S DISEASE
  83. A Population-Based Ultra-Widefield Digital Image Grading Study for Age-Related Macular Degeneration–Like Lesions at the Peripheral Retina
  84. Retinal imaging in early-onset Alzheimer’s disease
  85. Retinal nerve fibre layer (RNFL) thinning in genetic ftd
  86. Correction for Thompson et al., Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye
  87. Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye
  88. Metals in age-related macular degeneration
  89. Zinc-induced self-association of complement C3b and Factor H: Implications for inflammation and age-related macular degeneration
  90. Zinc-induced Self-association of Complement C3b and Factor H: IMPLICATIONS FOR INFLAMMATION AND AGE-RELATED MACULAR DEGENERATION
  91. Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular Degeneration
  92. The His402 allotype of complement factor H show similar self-association to the Tyr402 allotype but exhibits greater self-association in the presence of zinc
  93. Agreement between image grading of conventional (45°) and ultra wide-angle (200°) digital images in the macula in the Reykjavik eye study
  94. Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes
  95. Uncontrolled Zinc- and Copper-Induced Oligomerisation of the Human Complement Regulator Factor H and Its Possible Implications for Function and Disease
  96. Uncontrolled zinc- and copper-induced oligomerisation of human complement factor H and its implications for age-related macular degeneration
  97. Reply to “Comment on: “High concentration of zinc in sub-retinal pigment epithelial deposits” (Lengyel et al.) (Exp. Eye Res. 772–780, 84/4, 2007)”
  98. Comment on: “High concentration of zinc in sub-retinal pigment epithelial deposits” (Lengyel et al.) (Exp. Eye Res. 772–780, 84/4, 2007)
  99. Cure or cause: opposing roles for zinc in age-related macular degeneration
  100. Bio‐avalibale zinc in the outer segments of short wavelength cones
  101. High concentration of zinc in sub-retinal pigment epithelial deposits
  102. Partial and full agonism in endomorphin derivatives: Comparison by null and operational model
  103. Autonomous activity of CaMKII is only transiently increased following the induction of long-term potentiation in the rat hippocampus
  104. Association of Drusen Deposition with Choroidal Intercapillary Pillars in the Aging Human Eye
  105. Enhancement of NMDA responses by β-amyloid peptides in the hippocampus in vivo
  106. Enhanced G-protein activation by a mixture of Abeta(25-35), Abeta(1-40/42) and zinc
  107. S100B-Mediated Inhibition of the Phosphorylation of GFAP Is Prevented by TRTK-12
  108. Molecular pathomechanisms of Alzheimer's disease
  109. Side Chain Modifications Change the Binding and Agonist Properties of Endomorphin 2
  110. Influence of Degradation on Binding Properties and Biological Activity of Endomorphin 1
  111. Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy
  112. Preparation of specifically tritiated endomorphins
  113. Auto‐inhibition of Ca2+/calmodulin‐dependent protein kinase II by its ATP‐binding domain
  114. Autonomous activity and autophosphorylation of CAMPK‐II in rat hippocampal slices: effects of tissue preparation
  115. Modulation of the Phosphorylation and Activity of Calcium/Calmodulin‐Dependent Protein Kinase II by Zinc
  116. Phosphorylation of a New Brain-specific Septin, G-septin, by cGMP-dependent Protein Kinase
  117. Simultaneous measurement of tyrosine hydroxylase activity and phosphorylation in bovine adrenal chromaffin cells
  118. Phosphorylation of proteins in chick ciliary ganglion under conditions that induce long-lasting changes in synaptic transmission: phosphoprotein targets for nitric oxide action
  119. α and β subunits of CaM-kinase II are localized in different neurons in chick ciliary ganglion
  120. Characterization of protein kinase and phosphatase systems in chick ciliary ganglion
  121. Calcium/Calmodulin‐Stimulated Protein Kinase II Is Present in Primary Cultures of Cerebral Endothelial Cells
  122. Pathological Phosphorylation Causes Neuronal Death: Effect of Okadaic Acid in Primary Culture of Cerebellar Granule Cells
  123. Zinc can modulate the phosphorylation and activity of CAMK in freshly isolated rat brain capillaries
  124. Chapter 26: Regulation of transendothelial transport in the cerebral microvessels: the role of second messengers-generating systems
  125. Early X-irradiation of rats—4. Decrease in phosphorylation of low molecular weight proteins in the olfactory bulb accompanies the loss of GABAergic microneurons
  126. Kinetics of Protein Phosphorylation in Microvessels Isolated from Rat Brain: Modulation by Second Messengers